title: Amorolfine vs. ciclopirox - lacquers for the treatment of onychomycosis.
abstract: Amorolfine 5% and ciclopirox 8% nail lacquers are commonly used in topical treatment of onychomycosis. These formulations may be used alone or in combination with oral antifungal agents. Amorolfine and ciclopirox are valuable therapeutic options, however, their usage in monotherapy should be limited. Proper amorolfine and ciclopirox penetration through the nail plate is provided by transungual drug delivery systems. Although amorolfine and ciclopirox have a different mode of action, they both exhibit a broad antifungal activity. The use of antifungal nail lacquers in combination with oral agents, such as terbinafine and itraconazole, improves efficacy of antifungal therapy.
authors.affiliation: Department of Dermatology, Pediatric Dermatology and Dermatological Oncology, Medical University of Lodz, Lodz, Poland. Head of Department: Prof. Andrzej Kaszuba MD, PhD.
authors.forename: Katarzyna
authors.initials: K
authors.lastname: Tabara
authors.affiliation: Department of Dermatology, Pediatric Dermatology and Dermatological Oncology, Medical University of Lodz, Lodz, Poland. Head of Department: Prof. Andrzej Kaszuba MD, PhD.
authors.forename: Anna E
authors.initials: AE
authors.lastname: Szewczyk
authors.affiliation: Department of Dermatology, Pediatric Dermatology and Dermatological Oncology, Medical University of Lodz, Lodz, Poland. Head of Department: Prof. Andrzej Kaszuba MD, PhD.
authors.forename: Wojciech
authors.initials: W
authors.lastname: Bienias
authors.affiliation: Department of Dermatology, Pediatric Dermatology and Dermatological Oncology, Medical University of Lodz, Lodz, Poland. Head of Department: Prof. Andrzej Kaszuba MD, PhD.
authors.forename: Agnieszka
authors.initials: A
authors.lastname: Wojciechowska
authors.affiliation: Department of Dermatology, Pediatric Dermatology and Dermatological Oncology, Medical University of Lodz, Lodz, Poland. Head of Department: Prof. Andrzej Kaszuba MD, PhD.
authors.forename: Marta
authors.initials: M
authors.lastname: Pastuszka
authors.affiliation: Department of Dermatology, Pediatric Dermatology and Dermatological Oncology, Medical University of Lodz, Lodz, Poland. Head of Department: Prof. Andrzej Kaszuba MD, PhD.
authors.forename: Magdalena
authors.initials: M
authors.lastname: Oszukowska
authors.affiliation: Department of Dermatology, Pediatric Dermatology and Dermatological Oncology, Medical University of Lodz, Lodz, Poland. Head of Department: Prof. Andrzej Kaszuba MD, PhD.
authors.forename: Andrzej
authors.initials: A
authors.lastname: Kaszuba
keywords: amorolfine; ciclopirox; lacquer; onychomycosis
references.citation: Dermatol Clin. 2003 Jul;21(3):481-9
references.pmid: 12956200
references.citation: Clin Exp Dermatol. 1992 Sep;17 Suppl 1:44-9
references.pmid: 1458665
references.citation: Br J Dermatol. 2000 Jun;142(6):1177-83
references.pmid: 10848743
references.citation: Clin Exp Dermatol. 1992 Sep;17 Suppl 1:61-70
references.pmid: 1458669
references.citation: Br J Dermatol. 2001 Oct;145 Suppl 60:9-13
references.pmid: 11777263
references.citation: Arch Dermatol. 2006 Oct;142(10):1279-84
references.pmid: 17043182
references.citation: An Bras Dermatol. 2012 Jan-Feb;87(1):19-25
references.pmid: 22481647
references.citation: Dermatol Ther. 2007 Jan-Feb;20(1):31-46
references.pmid: 17403258
references.citation: Clin Exp Dermatol. 1992 Sep;17 Suppl 1:41-3
references.pmid: 1458664
references.citation: Br J Dermatol. 2012 Jun;166(6):1360-2
references.pmid: 22136723
references.citation: Br J Dermatol. 1995 Nov;133(5):699-703
references.pmid: 8555019
references.citation: J Eur Acad Dermatol Venereol. 2013 Feb;27(2):e153-8
references.pmid: 22449201
references.citation: Mycoses. 2012 Nov;55(6):541-51
references.pmid: 22540995
references.citation: Br J Dermatol. 2003 Sep;149 Suppl 65:1-4
references.pmid: 14510968
references.citation: J Am Acad Dermatol. 2000 Oct;43(4 Suppl):S70-80
references.pmid: 11051136
references.citation: Br J Dermatol. 2003 Jul;149(1):151-6
references.pmid: 12890209
references.citation: J Eur Acad Dermatol Venereol. 2009 Jul;23(7):773-81
references.pmid: 19453778
references.citation: J Am Acad Dermatol. 2000 Oct;43(4 Suppl):S57-69
references.pmid: 11051135
references.citation: J Eur Acad Dermatol Venereol. 2005 Sep;19 Suppl 1:25-33
references.pmid: 16120203
references.citation: J Am Podiatr Med Assoc. 2000 Nov-Dec;90(10):495-501
references.pmid: 11107710
references.citation: Mycoses. 1990 Apr;33(4):167-71
references.pmid: 2146498
references.citation: Int J Dermatol. 1997 Oct;36(10):788-92
references.pmid: 9372359
references.citation: J Eur Acad Dermatol Venereol. 2005 Jan;19(1):21-9
references.pmid: 15649187
references.citation: J Eur Acad Dermatol Venereol. 2010 Aug;24(8):910-5
references.pmid: 20028447
references.citation: Br J Dermatol. 2007 Jul;157(1):149-57
references.pmid: 17553051
references.citation: Clin Exp Dermatol. 1992 Sep;17 Suppl 1:8-12
references.pmid: 1458670
references.citation: J Eur Acad Dermatol Venereol. 2005 Sep;19 Suppl 1:1-7
references.pmid: 16120198
references.citation: J Clin Pharm Ther. 2010 Oct;35(5):497-519
references.pmid: 20831675
references.citation: Drugs. 2010 Nov 12;70(16):2133-52
references.pmid: 20964457
references.citation: Br J Dermatol. 1992 Feb;126 Suppl 39:23-7
references.pmid: 1531924
references.citation: J Drugs Dermatol. 2010 Sep;9(9):1109-13
references.pmid: 20865843
references.citation: Clin Microbiol Rev. 1998 Jul;11(3):415-29
references.pmid: 9665975
references.citation: J Dermatolog Treat. 2005;16(5-6):327-30
references.pmid: 16428154
references.citation: Acta Derm Venereol. 1996 Jan;76(1):83-4
references.pmid: 8721508
references.citation: Br J Dermatol. 1999 Nov;141 Suppl 56:1-4
references.pmid: 10730907
references.citation: Int J Dermatol. 2004 Jul;43 Suppl 1:3-8
references.pmid: 15271193
references.citation: J Eur Acad Dermatol Venereol. 2005 Sep;19 Suppl 1:8-12
references.pmid: 16120199
references.citation: J Dtsch Dermatol Ges. 2010 Nov;8(11):875-9
references.pmid: 20738460